Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties

References

• Huang MT Ho CT Wang ZY Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid Cancer Res 1994 54 3 701 708 8306331
   PubMed Web of Science ®Google Scholar
• Nishino H Nishino A Takayasu J Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds Cancer Res 1988 48 18 5210 5215 3409245
   PubMed Web of Science ®Google Scholar
• Honda T Rounds BV Gribble GW Suh NJ Wang YP Sporn MB Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages Bioorg Med Chem Lett 1998 8 19 2711 2714 9873608
   PubMed Web of Science ®Google Scholar
• Suh NJ Wang YP Honda T A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity Cancer Res 1999 59 2 336 341 9927043
   PubMed Web of Science ®Google Scholar
• Konopleva M Tsao T Estrov Z The synthetic triterpenoid 2-cyano-3, 12-dioxooleana-1,9-dien-28-oic acid induces caspase-dependent and -independent apoptosis in acute myelogenous leukemia Cancer Res 2004 64 21 7927 7935 15520199
   PubMed Web of Science ®Google Scholar
• Honda T Rounds BV Bore L Synthetic oleanane and ursane triterpenoids with modified rings A and C: A series of highly active inhibitors of nitric oxide production in mouse macrophages J Med Chem 2000 43 22 4233 4246 11063620
   PubMed Web of Science ®Google Scholar
• Liby K Royce DB Williams CR The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice Cancer Res 2007 67 6 2414 2419 17363558
   PubMed Web of Science ®Google Scholar
• Chintharlapalli S Papineni S Konopleva M Andreef M Samudio I Safe S 2-Cyano-3, 12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor-γ-dependent and -independent pathways Mol Pharmacol 2005 68 1 119 128 15798084
   PubMed Web of Science ®Google Scholar
• Konopleva M Tsao T Ruvolo P Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia Blood 2002 99 1 326 335 11756188
   PubMed Web of Science ®Google Scholar
• Ikeda T Sporn M Honda T Gribble GW Kufe D The novel triterpenoid CDDO and its derivatives induce apoptosis by disruption of intracellular redox balance Cancer Res 2003 63 17 5551 5558 14500394
   PubMed Web of Science ®Google Scholar
• Hyer ML Shi R Krajewska M Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer Cancer Res 2008 68 8 2927 2933 18413762
   PubMed Web of Science ®Google Scholar
• Yates MS Tauchi M Katsuoka F Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes Mol Cancer Ther 2007 6 1 154 162 17237276
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT Liby KT Stephenson KK Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress Proc Natl Acad Sci U S A 2005 102 12 4584 4589 15767573
   PubMed Web of Science ®Google Scholar
• Liby KT Yore MM Sporn MB Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer Nat Rev Cancer 2007 7 5 357 369 17446857
   PubMed Web of Science ®Google Scholar
• Liby KT Sporn MB Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease Pharmacol Rev 2012 64 4 972 1003 22966038
   PubMed Web of Science ®Google Scholar
• de Zeeuw D Akizawa T Audhya P Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease N Engl J Med 2013 369 26 2492 2503 24206459
   PubMed Web of Science ®Google Scholar
• Nagaraj S Youn JI Weber H Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer Clin Cancer Res 2010 16 6 1812 1823 20215551
   PubMed Web of Science ®Google Scholar
• Hong DS Kurzrock R Supko JG A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas Clin Cancer Res 2012 18 12 3396 3406 22634319
   PubMed Web of Science ®Google Scholar
• Sporn MB Liby KT Yore MM Fu LF Lopchuk JM Gribble GW New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress J Nat Prod 2011 74 3 537 545 21309592
   PubMed Web of Science ®Google Scholar
• Pollier J Goossens A Oleanolic acid Phytochemistry 2012 77 10 15 22377690
   PubMed Web of Science ®Google Scholar
• Couch RD Browning RG Honda T Studies on the reactivity of CDDO, a promising new chemopreventive and chemotherapeutic agent: implications for a molecular mechanism of action Bioorg Med Chem Lett 2005 15 9 2215 2219 15837296
   PubMed Web of Science ®Google Scholar
• Yore MM Kettenbach AN Sporn MB Gerber SA Liby KT Proteomic analysis shows synthetic oleanane triterpenoid binds to mTOR PLoS One 2011 6 7 e22862 21818401
   PubMed Web of Science ®Google Scholar
• Wang YP Porter WW Suh NJ A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor-γ Mol Endocrinol 2000 14 10 1550 1556 11043571
   PubMed Web of Science ®Google Scholar
• Kawamoto Y Nakamura Y Naito Y Cyclopentenone prostaglandins as potential inducers of phase II detoxification enzymes. 15-deoxy-Δ12,14-prostaglandin J2-induced expression of glutathione S-transferases J Biol Chem 2000 275 15 11291 11299 10753940
   PubMed Web of Science ®Google Scholar
• Rossi A Kapahi P Natoli G Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase Nature 2000 403 6765 103 108 10638762
   PubMed Web of Science ®Google Scholar
• Levonen AL Landar A Ramachandran A Cellular mechanisms of redox cell signalling: Role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products Biochem J 2004 378 pt 2 373 382 14616092
   PubMed Web of Science ®Google Scholar
• Straus DS Pascual G Li M 15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway Proc Natl Acad Sci U S A 2000 97 9 4844 4849 10781090
   PubMed Web of Science ®Google Scholar
• Ahmad R Raina D Meyer C Kharbanda S Kufe D Triterpenoid CDDO-Me blocks the NF-κB pathway by direct inhibition of IKKβ on Cys-179 J Biol Chem 2006 281 47 35764 35769 16998237
   PubMed Web of Science ®Google Scholar
• Walsh J Jenkins RE Wong M Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: Biochemical, pharmacological and toxicological implications J Proteomics 2014 108 171 187 24859727
   PubMed Web of Science ®Google Scholar
• Thomas M A preliminary evaluation of bardoxolone methyl for the treatment of diabetic nephropathy Expert Opin Drug Metab Toxicol 2012 8 8 1015 1022 22747345
   PubMed Web of Science ®Google Scholar
• Aleksunes LM Goedken MJ Rockwell CE Thomale J Manautou JE Klaassen CD Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity J Pharmacol Exp Ther 2010 335 1 2 12 20605904
   PubMed Web of Science ®Google Scholar
• Wu QQ Wang Y Senitko M Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1 Am J Physiol Renal Physiol 2011 300 5 F1180 F1192 21289052
   PubMed Web of Science ®Google Scholar
• Wu J Liu X Fan J Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway Toxicology 2014 318 22 31 24530882
   PubMed Web of Science ®Google Scholar
• Yoh K Hirayama A Ishizaki K Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice Genes to Cells 2008 13 11 1159 1170 19090810
   PubMed Web of Science ®Google Scholar
• Yoh K Itoh K Enomoto A Nrf2-deficient female mice develop lupus-like autoimmune nephritis Kidney Int 2001 60 4 1343 1353 11576348
   PubMed Web of Science ®Google Scholar
• Liu M Grigoryev DN Crow MT Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice Kidney Int 2009 76 3 277 285 19436334
   PubMed Web of Science ®Google Scholar
• Pergola PE Krauth M Huff JW Effect of bardoxolone methyl on kidney function in patients with T2D and stage 3b–4 CKD Am J Nephrol 2011 33 5 469 476 21508635
   PubMed Web of Science ®Google Scholar
• Pergola PE Raskin P Toto RD Bardoxolone methyl and kidney function in CKD with type 2 diabetes N Engl J Med 2011 365 4 327 336 21699484
   PubMed Web of Science ®Google Scholar
• Ruiz S Pergola PE Zager RA Vaziri ND Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease Kidney Int 2013 83 6 1029 1041 23325084
   PubMed Web of Science ®Google Scholar
• Reisman SA Chertow GM Hebbar S Vaziri ND Ward KW Meyer CJ Bardoxolone methyl decreases megalin and activates Nrf2 in the kidney J Am Soc Nephrol 2012 23 10 1663 1673 22859857
   PubMed Web of Science ®Google Scholar
• Ding YF Stidham RD Bumeister R The synthetic triterpenoid, RTA 405, increases the glomerular filtration rate and reduces angiotensin II-induced contraction of glomerular mesangial cells Kidney Int 2013 83 5 845 854 23235569
   PubMed Web of Science ®Google Scholar
• Zhang DD Bardoxolone brings Nrf2-based therapies to light Antioxid Redox Signal 2013 19 5 517 518 23227819
   PubMed Web of Science ®Google Scholar
• Tayek JA Kalantar-Zadeh K The extinguished BEACON of bardoxolone: not a Monday morning quarterback story Am J Nephrol 2013 37 3 208 211 23466901
   PubMed Web of Science ®Google Scholar
• Ruggenenti P Porrini EL Gaspari F Glomerular hyperfiltration and renal disease progression in type 2 diabetes Diabetes Care 2012 35 10 2061 2068 22773704
   PubMed Web of Science ®Google Scholar
• Zoja C Benigni A Remuzzi G The Nrf2 pathway in the progression of renal disease Nephrol Dialysis Transplant 2014 29 suppl 1 i19 i24
   PubMed Web of Science ®Google Scholar
• Liby KT Synthetic triterpenoids can protect against toxicity without reducing the efficacy of treatment with carboplatin and paclitaxel in experimental lung cancer Dose Response 2014 12 1 136 151 24659938
   PubMed Web of Science ®Google Scholar
• Deeb D Gao XH Liu YB Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling Carcinogenesis 2011 32 5 757 764 21325633
   PubMed Web of Science ®Google Scholar
• Gao X Deeb D Liu Y Prevention of prostate cancer with oleanane synthetic triterpenoid CDDO-Me in the TRAMP mouse model of prostate cancer Cancers (Basel) 2011 3 3 3353 3369 21961053
   PubMedGoogle Scholar
• Liu YB Gao XH Deeb D Arbab AS Gautam SC Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer Molecules 2012 17 12 14795 14809 23519253
   PubMed Web of Science ®Google Scholar
• Liby K Risingsong R Royce DB Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl ester and the rexinoid LG100268 Clin Cancer Res 2008 14 14 4556 4563 18628471
   PubMed Web of Science ®Google Scholar
• Tran K Risingsong R Royce D Williams CR Sporn MB Liby K The synthetic triterpenoid CDDO-methyl ester delays estrogen receptor-negative mammary carcinogenesis in polyoma middle T mice Cancer Prev Res 2012 5 5 726 734
   Web of Science ®Google Scholar
• Kim EH Deng CX Sporn MB CDDO-methyl ester delays breast cancer development in Brca1-mutated mice Cancer Prev Res 2012 5 1 89 97
   Web of Science ®Google Scholar
• Liby KT Royce DB Risingsong R Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer Cancer Prev Res 2010 3 11 1427 1434
   PubMed Web of Science ®Google Scholar
• Wang YY Zhe H Zhao R Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment Mol Cancer 2014 13 30 24552536
   PubMed Web of Science ®Google Scholar
• Deeb D Gao X Liu Y Varma NR Arbab AS Gautam SC Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent Molecules 2013 18 3 3250 3265 23486104
   PubMed Web of Science ®Google Scholar
• Gao X Liu Y Deeb D ROS mediate proapoptotic and antisurvival activity of oleanane triterpenoid CDDO-Me in ovarian cancer cells Anticancer Res 2013 33 1 215 221 23267148
   PubMed Web of Science ®Google Scholar
• Qin Y Deng W Ekmekcioglu S Grimm EA Identification of unique sensitizing targets for anti-inflammatory CDDO-Me in metastatic melanoma by a large-scale synthetic lethal RNAi screening Pigment Cell Melanoma Res 2013 26 1 97 112 23020131
   PubMed Web of Science ®Google Scholar
• Deeb D Gao X Liu Y Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity Biochem Biophys Res Commun 2012 422 4 561 567 22609405
   PubMed Web of Science ®Google Scholar
• Liu Y Gao X Deeb D Gautam SC Oleanane triterpenoid CDDO-Me inhibits Akt activity without affecting PDK1 kinase or PP2A phosphatase activity in cancer cells Biochem Biophys Res Commun 2012 417 1 570 575 22177954
   PubMed Web of Science ®Google Scholar
• Gao X Liu Y Deeb D Synthetic oleanane triterpenoid, CDDO-Me, induces apoptosis in ovarian cancer cells by inhibiting prosurvival AKT/NF-kappaB/mTOR signaling Anticancer Res 2011 31 11 3673 3681 22110186
   PubMed Web of Science ®Google Scholar
• Deeb D Gao X Arbab AS Barton K Dulchavsky SA Gautam SC CDDO-Me: A novel synthetic triterpenoid for the treatment of pancreatic cancer Cancers (Basel) 2010 2 4 1779 1793 21799944
   PubMedGoogle Scholar
• Ahmad R Liu S Weisberg E Combining the FLT3 inhibitor PKC412 and the triterpenoid CDDO-Me synergistically induces apoptosis in acute myeloid leukemia with the internal tandem duplication mutation Mol Cancer Res 2010 8 7 986 993 20571062
   PubMed Web of Science ®Google Scholar
• Ryu K Susa M Choy E Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway BMC Cancer 2010 10 187 20459702
   PubMed Web of Science ®Google Scholar
• Yang C Hornicek FJ Wood KB Blockage of Stat3 with CDDO-Me inhibits tumor cell growth in chordoma Spine (Phila Pa 1976) 2010 35 18 1668 1675 20386502
   PubMed Web of Science ®Google Scholar
• Deeb D Gao X Jiang H Dulchavsky SA Gautam SC Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR Prostate 2009 69 8 851 860 19189297
   PubMed Web of Science ®Google Scholar
• Zou W Yue P Khuri FR Sun SY Coupling of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of death receptor 5 via a CHOP-dependent mechanism involving JNK activation Cancer Res 2008 68 18 7484 7492 18794136
   PubMed Web of Science ®Google Scholar
• Duan Z Ames RY Ryan M Hornicek FJ Mankin H Seiden MV CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells Cancer Chemother Pharmacol 2009 63 4 681 689 18587580
   PubMed Web of Science ®Google Scholar
• Zou W Chen S Liu X c-FLIP downregulation contributes to apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells Cancer Biol Ther 2007 6 10 1614 1620 18253090
   PubMed Web of Science ®Google Scholar
• Deeb D Gao X Dulchavsky SA Gautam SC CDDO-Me induces apoptosis and inhibits Akt, mTOR and NF-κB signaling proteins in prostate cancer cells Anticancer Res 2007 27 5A 3035 3044 17970042
   PubMed Web of Science ®Google Scholar
• Shishodia S Sethi G Konopleva M Andreeff M Aggarwal BB A synthetic triterpenoid, CDDO-Me, inhibits IκBα kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor κB-regulated gene products in human leukemic cells Clin Cancer Res 2006 12 6 1828 1838 16551868
   PubMed Web of Science ®Google Scholar
• Ahmad R Raina D Meyer C Kufe D Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1) → signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3 Cancer Res 2008 68 8 2920 2926 18413761
   PubMed Web of Science ®Google Scholar
• Zou W Liu XG Yue P c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells Cancer Res 2004 64 20 7570 7578 15492284
   PubMed Web of Science ®Google Scholar
• Gao X Deeb D Hao J Synthetic triterpenoids inhibit growth, induce apoptosis and suppress pro-survival Akt, mTOR and NF-κB signaling proteins in colorectal cancer cells Anticancer Res 2010 30 3 785 792 20392997
   PubMed Web of Science ®Google Scholar
• Youn JI Gabrilovich DI The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity Eur J Immunol 2010 40 11 2969 2975 21061430
   PubMed Web of Science ®Google Scholar
• Gao X Deeb D Jiang H Liu Y Dulchavsky SA Gautam SC Synthetic triterpenoids inhibit growth and induce apoptosis in human glioblastoma and neuroblastoma cells through inhibition of prosurvival Akt, NF-κB and Notch1 signaling J Neurooncol 2007 84 2 147 157 17361329
   PubMed Web of Science ®Google Scholar
• Samudio I Kurinna S Ruvolo P Inhibition of mitochondrial metabolism by methyl-2-cyano-3,12-dioxooleana-1,9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells Mol Cancer Ther 2008 7 5 1130 1139 18483301
   PubMed Web of Science ®Google Scholar
• Samudio I Konopleva M Pelicano H A novel mechanism of action of methyl-2-cyano-3,12 dioxoolean-1,9 diene-28-oate: direct permeabilization of the inner mitochondrial membrane to inhibit electron transport and induce apoptosis Mol Pharmacol 2006 69 4 1182 1193 16410408
   PubMed Web of Science ®Google Scholar
• Liby K Risingsong R Royce DB Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice Cancer Prev Res 2009 2 12 1050 1058
   Web of Science ®Google Scholar
• Jutooru I Chadalapaka G Abdelrahim M Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a Mol Pharmacol 2010 78 2 226 236 20488920
   PubMed Web of Science ®Google Scholar
• Mitsuishi Y Motohashi H Yamamoto M The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism Front Oncol 2012 2 200 23272301
   PubMedGoogle Scholar
• Petronelli A Pannitteri G Testa U Triterpenoids as new promising anticancer drugs Anticancer Drug 2009 20 10 880 892
   Google Scholar
• Shanmugam MK Dai XY Kumar AP Tan BKH Sethi G Bishayee A Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence Cancer Lett 2014 346 2 206 216 24486850
   PubMed Web of Science ®Google Scholar
• Tran TA McCoy MK Sporn MB Tansey MG The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection J Neuroinflammation 2008 5 14 18474101
   PubMed Web of Science ®Google Scholar
• Kim SB Pandita RK Eskiocak U Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiation Proc Natl Acad Sci U S A 2012 109 43 E2949 E2955 23045680
   PubMed Web of Science ®Google Scholar
• Eskiocak U Kim SB Roig AI CDDO-Me protects against space radiation-induced transformation of human colon epithelial cells Radiat Res 2010 174 1 27 36 20681796
   PubMed Web of Science ®Google Scholar
• Kim SB Ly P Kaisani A Zhang L Wright WE Shay JW Mitigation of radiation-induced damage by targeting EGFR in noncancerous human epithelial cells Radiat Res 2013 180 3 259 267 23919312
   PubMed Web of Science ®Google Scholar
• Kulkarni AA Thatcher TH Hsiao HM The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis PLoS One 2013 8 5 e63798 23741300
   PubMed Web of Science ®Google Scholar
• Kuriyan AE Lehmann GM Kulkarni AA Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring Exp Eye Res 2012 94 1 136 145 22178289
   PubMed Web of Science ®Google Scholar
• Auletta JJ Alabran JL Kim BG Meyer CJ Letterio JJ The synthetic triterpenoid, CDDO-Me, modulates the proinflammatory response to in vivo lipopolysaccharide challenge J Interferon Cytokine Res 2010 30 7 497 508 20626291
   PubMed Web of Science ®Google Scholar
• Saha PK Reddy VT Konopleva M Andreeff M Chan L The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic-acid methyl ester has potent anti-diabetic effects in diet-induced diabetic mice and Lepr db/db mice J Biolog Chem 2010 285 52 40581 40592
   PubMed Web of Science ®Google Scholar
• D’Alto M Diller GP Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome: current advanced management strategies Heart 2014 100 17 1322 1328 24829371
   PubMed Web of Science ®Google Scholar
• Chin MP Reisman SA Bakris GL Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl Am J Nephrol 2014 39 6 499 508 24903467
   PubMed Web of Science ®Google Scholar
• Xie YH Wang SW Zhang Y Edvinsson L Xu CB Nuclear factor-κB-mediated endothelin receptor up-regulation increases renal artery contractility in rats Basic Clin Pharmacol Toxicol Epub 2013 8 22
   Web of Science ®Google Scholar
• Ames E Harouna S Meyer C Welniak LA Murphy WJ The triterpenoid CDDO-Me promotes hematopoietic progenitor expansion and myelopoiesis in mice Biol Blood Marrow Transplant 2012 18 3 396 405 22100978
   PubMed Web of Science ®Google Scholar
• Li M Sun K Redelman D Welniak LA Murphy WJ The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation Biol Blood Marrow Transplant 2010 16 6 739 750 20338256
   PubMed Web of Science ®Google Scholar